About Us
About Taiai Peptide Group
Taiai Peptide Group, founded in 1997, is a large-scale high-tech corporation specializing in the R&D, production and sales of protein peptide raw powder and protein peptide functional formulation. The headquarter is located in Beijing. Taiai Peptide Group owns three large-scale production bases in Liaoning, Hebei and Shandong, with an annual production of 10000 tons of bioactive peptides, and is the world’s largest producer of collagen peptide raw materials.
Our bioactive peptide include Animal Protein Peptide and Vegetable Protein Peptide. For finsihed product, We can supply OEM、ODM and customized production service.
As a powerful enterprise focusing on the research field of Small Molecule Peptide, we has core competitiveness with many patents in the Peptide Industry. We attach great importance to quality and have FDA, ISO, HACCP, FSSC certification.
Provide overall solutions such as original powder, ODM, OEM,
brand agency and so on for the world. It is a global high-level partner of peptide industry.
Factory display
The group has a modern production base of more than 600 acres, a research and development building of more than 6,000 square meters, a 100,000-level GMP workshop standard, an annual production capacity of more than 5,000 tons of small molecule peptide raw materials and products, and more than 50 kinds of independent products. It has a number of core technology patents in the peptide industry: its own single-substance extraction technology, full-substance chain extraction technology, its own enzymatic hydrolysis technology, and more than 300 scientific research achievements such as the core technology for the extraction of small molecule peptides from herbs.
Under the strategic sector of health and nutrition, we strictly abide by international production standards, and have international production system certifications such as HACCP hazard analysis and critical control point system, ISO22000 food safety management system, and FSSC 22000. We focus on technological innovation, developing innovative raw materials to meet market demands for solutions that provide effective, completely safe and high-quality products.
Over the years, Taiai Peptide has conducted in-depth cooperation with many scientific research institutions, universities and hospitals, as well as Ren Yandong, Zhang Li, Lu Tao, Yang Yanjun and other well-known experts and scholars in the industry. In 2021, we will cooperate with the School of Food Science of Jiangnan University to jointly establish a joint research and development center for peptide substances. Through the cooperation and complementation of research and development technology, we will continuously improve the transformation of Taiai peptide scientific research results.
Team photos
In the era of great health, Taiai Peptide has developed into a dream that can carry wealth creation, and will use its strong R&D strength and ingenious quality to provide cooperative enterprises, provide all-round empowerment, provide nanny services, and tailor-made exclusive product IP; Carry forward the Chinese peptide culture, create benefits for customers; create more value for the big health industry; finally achieve the goal of serving human health and benefit mankind!
COMPANY CULTURE
Let the common people drink the peptides and have a good body.
To be a century-old enterprise in the health industry, and to serve 100 million households in 2030.
Integrity
Customer first
Technological innovation
Team progress
Development history of the company
2021
The new office area will be completed and put into operation.
2020
Tai Ai Peptide became the China Health Care Association and the chairman of the peptide industry, the global strategic partner of the peptide industry.
2018
The China Health Annual Conference awarded the "Lifetime Achievement Award" as one of the top ten industry brands.
2013
"China Today" interviewed the small molecule active peptide developed by it and passed the test of Wu doping by the National Doping Testing and Research Center.
2010
The Ministry of Science and Technology "China Magazine" interviewed and shared small molecule active collagen peptides.
2009
The Dalian collagen factory covering an area of 400 mu was built and put into operation.
2007
The self-developed peptide extraction technology won the national patent, and successfully achieved the technological breakthrough of collagen peptides from macromolecules to small fractions.
2006
The factory in Hebei Province covering an area of 150 acres was completed, and the GMP production R&D base was put into operation.
2003
We accepted an exclusive interview with China Central Television on the research and development of truth-telling peptides.
1997
Started the research and development of small molecule active peptides.